Pharma Journalist -

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced that it has entered into a clinical collaboration agreement with Merck, known as MSD outside of…
Read More...

Equillium Inc. a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, and…
Read More...

SMi Reports: HK Packaging Consulting GmbH to present at Pre-Filled Syringes and Injectable Drug Devices conference 2020, this January. The Pre-Filled Syringes and Injectable Drug…
Read More...

SMi Reports: Dr Samareh Lajaunias, Director at Combioxin will be speaking at SMi’s 22nd Annual Superbugs & Superdrugs Conference in London in March 2020 The 22nd Annual Superbugs…
Read More...

SMi Reports: Invitation from conference chair Lynne Ensor for Pharmaceutical Microbiology East Coast 2020 in Boston SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference…
Read More...

Regeneron Pharmaceuticals and Sanofi announced their intent to simplify their antibody collaboration for Kevzara (sarilumab) and Praluent (alirocumab) by restructuring into a…
Read More...

Amneal Pharmaceuticals, Inc. and AvKARE Inc. announced they have entered into a definitive agreement under which Amneal will acquire a 65.1% majority interest in AvKARE and its related…
Read More...

Flagship Pioneering, a unique life sciences innovation enterprise, unveiled Cellarity, a first-of-its-kind therapeutics company that is discovering and developing medicines by studying…
Read More...

Dermira, a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with…
Read More...

UK-based biotechnology company Retrogenix and US-based Resonant Therapeutics, Inc. announced that they have entered into a non-exclusive strategic partnership to identify the targets of…
Read More...